These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34080560)

  • 1. Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program.
    Jones AA; Park JN; Allen ST; Schneider KE; Weir BW; Hunt D; Sherman SG
    J Subst Abuse Treat; 2021 Oct; 129():108412. PubMed ID: 34080560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Take-home naloxone possession among people who inject drugs in rural West Virginia.
    Allen ST; White RH; O'Rourke A; Grieb SM; Kilkenny ME; Sherman SG
    Drug Alcohol Depend; 2019 Nov; 204():107581. PubMed ID: 31574407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
    Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
    Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities.
    Dietze PM; Stare M; Cogger S; Nambiar D; Olsen A; Burns L; Lenton S
    Drug Alcohol Rev; 2018 May; 37(4):457-463. PubMed ID: 29744979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone.
    Schneider KE; O'Rourke A; White RH; Park JN; Musci RJ; Kilkenny ME; Sherman SG; Allen ST
    Int J Drug Policy; 2020 Feb; 76():102642. PubMed ID: 31918401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
    Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
    Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland.
    Buresh M; Gicquelais RE; Astemborski J; Kirk GD; Mehta SH; Genberg BL
    PLoS One; 2020; 15(3):e0230127. PubMed ID: 32160244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting.
    Holmén E; Hammarberg A; Kåberg M; Storbjörk J
    Int J Drug Policy; 2023 May; 115():104021. PubMed ID: 37011507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racialized environments and syringe services program implementation: County-level factors.
    Bluthenthal RN; Humphrey JL; Strack CN; Wenger LD; LaKosky P; Patel SV; Kral AH; Lambdin B
    Drug Alcohol Depend; 2024 Oct; 263():112430. PubMed ID: 39216198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities in use of syringe service programs in King County, WA: a comparison of two cross-sectional surveys.
    Salow K; Jack HE; Tinsley J; Banta-Green CJ; Kingston S; Iles-Shih M; Tsui JI; Glick S
    Harm Reduct J; 2023 Sep; 20(1):133. PubMed ID: 37704989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Once I'd done it once it was like writing your name": Lived experience of take-home naloxone administration by people who inject drugs.
    McAuley A; Munro A; Taylor A
    Int J Drug Policy; 2018 Aug; 58():46-54. PubMed ID: 29803097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis.
    Schneider KE; Park JN; Allen ST; Weir BW; Sherman SG
    Drug Alcohol Depend; 2019 Aug; 201():71-77. PubMed ID: 31195347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs.
    Reed M; Wagner KD; Tran NK; Brady KA; Shinefeld J; Roth A
    Int J Drug Policy; 2019 Nov; 73():32-35. PubMed ID: 31336291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection Drug Use Frequency Before and After Take-Home Naloxone Training.
    Colledge-Frisby S; Rathnayake K; Nielsen S; Stoove M; Maher L; Agius PA; Higgs P; Dietze P
    JAMA Netw Open; 2023 Aug; 6(8):e2327319. PubMed ID: 37540514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
    Curtis M; Dietze P; Aitken C; Kirwan A; Kinner SA; Butler T; Stoové M
    Harm Reduct J; 2018 Sep; 15(1):48. PubMed ID: 30241532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people's perceptions of the BC take home naloxone program.
    Mitchell K; Durante SE; Pellatt K; Richardson CG; Mathias S; Buxton JA
    Harm Reduct J; 2017 Jun; 14(1):34. PubMed ID: 28592287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
    Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
    Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
    O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
    BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone distribution and possession following a large-scale naloxone programme.
    Madah-Amiri D; Gjersing L; Clausen T
    Addiction; 2019 Jan; 114(1):92-100. PubMed ID: 30129078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.